e-learning
resources
Virtual 2020
Pre-Congress Content
Chronic lung diseases: novel methods, diagnostics and biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Early exploratory use of omic approaches to assess metabolite changes in COPD
T. Kramaric (Aberystwyth (Dyfed), United Kingdom), S. Thomas (Aberystwyth (Dyfed), United Kingdom), K. Love (Aberystwyth (Dyfed), United Kingdom), I. Bond (Cardiff, United Kingdom), D. Rooke (Cardiff, United Kingdom), L. Mur (Aberystwyth (Dyfed), United Kingdom), K. Lewis (Swansea, United Kingdom)
Source:
Virtual Congress 2020 – Chronic lung diseases: novel methods, diagnostics and biomarkers
Session:
Chronic lung diseases: novel methods, diagnostics and biomarkers
Session type:
E-poster session
Number:
322
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Kramaric (Aberystwyth (Dyfed), United Kingdom), S. Thomas (Aberystwyth (Dyfed), United Kingdom), K. Love (Aberystwyth (Dyfed), United Kingdom), I. Bond (Cardiff, United Kingdom), D. Rooke (Cardiff, United Kingdom), L. Mur (Aberystwyth (Dyfed), United Kingdom), K. Lewis (Swansea, United Kingdom). Late Breaking Abstract - Early exploratory use of omic approaches to assess metabolite changes in COPD. 322
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Late Breaking Abstract - Validation of a tool for the assessment of disease awareness (DA) in COPD
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017
Late Breaking Abstract - Capnography for ultimately simple diagnostics of COPD
Source: International Congress 2017 – Innovation in COPD: techniques and facts
Year: 2017
Late Breaking Abstract - Geographic accessibility and chronic respiratory disease outcomes: a decision support tool
Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry
Year: 2019
Late Breaking Abstract - iPREDICT: Pilot study to develop predictive model of changes in asthma control
Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases
Year: 2019
Late Breaking Abstract - Longitudinal analysis of variation in clinical features from the U-BIOPRED severe asthma cohort
Source: International Congress 2018 – Notable Studies in Asthma
Year: 2018
Late Breaking Abstract - Corticosteroid optimisation in severe asthma using composite biomarkers to adjust dose versus a symptom/risk-based algorithm
Source: Virtual Congress 2020 – ALERT: Asthma in adults and children
Year: 2020
Late Breaking Abstract - Detection of clinical instability by eNose in COPD patients
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
Late Breaking Abstract - ND-L02-s0201 treatment leads to efficacy in preclinical IPF models
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017
Late Breaking Abstract - Automated coaching for physical activity in COPD patients: results from a pilot study
Source: International Congress 2017 – Innovation in pulmonary rehabilitation and chronic care
Year: 2017
Late Breaking Abstract - Recurrent Neural Networks and environmental data for COPD exacerbation prediction
Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases
Year: 2020
Late Breaking Abstract - Pilot study for a new diagnostic supply process for patients with sleep related breathing disorders
Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality
Year: 2018
Late Breaking Abstract - Implications of new PH definition for CTEPD
Source: Virtual Congress 2021 – Therapy of pulmonary hypertension
Year: 2021
Late Breaking Abstract - Identifying and addressing patient beliefs driving SABA use and over-reliance
Source: International Congress 2019 – Novel findings from asthma clinical trials
Year: 2019
Late Breaking Abstract - Defining a severe asthma super-responder: findings from a Delphi process
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020
Late Breaking Abstract - Validation of Hexoskin biometric technology to monitor ventilatory responses at rest and during exercise in COPD
Source: International Congress 2017 – Late-breaking findings in asthma and COPD
Year: 2017
Late Breaking Abstract - Comparison of the blood transcriptomic profiles of adults and children from the U-BIOPRED asthma study
Source: International Congress 2017 – Small airways, long distances and large databases in paediatric asthma
Year: 2017
Late Breaking Abstract: An animal model for studies on pathogenesis and pharmaceutical intervention of chronic asthma
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
Plasma metabolomic signature in COPD patients: Associations to proteomic profile and clinical outcomes
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Late Breaking Abstract - Lung function tests in patients with previous SARS-COV2 pneumonia: a useful follow-up tool
Source: Virtual Congress 2021 – Exacerbations of chronic respiratory diseases, including SARS-CoV-2
Year: 2021
Late Breaking Abstract - MicroRNA profiling informs on the pulmonary sequelae of COVID-19-induced ARDS
Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept